Completed
Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
NCT02419391
- Conditions
- Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
- Locations
-
- Johnson County Clin-Trials (JCCT) Lenexa, Kansas, United States